PTHS
Pelthos Therapeutics Inc.
20.50$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +4,082.5% | -35.4% | -17.8% | -36.0% | -33.4% | -9.7% | +15,265.3% | +3.1% | +11.5% | -5.5% | |
| – | +4,082.5% | -35.4% | -17.8% | -36.0% | -33.4% | -9.7% | +5,861.0% | +7.4% | +31.1% | -8.3% | |
| – | +3,811.4% | -36.2% | -47.8% | -59.1% | -74.4% | -54.9% | +23,987.4% | +26.5% | +78.8% | -23.8% | |
| – | +3,811.4% | -36.2% | -47.8% | -59.1% | -74.4% | -54.9% | +23,987.4% | +26.5% | +78.8% | -23.8% | |
| – | – | +0.0% | +0.0% | +0.0% | +0.0% | +0.0% | +19,672.3% | +10.9% | +32.1% | +23.8% | |
| – | – | – | – | – | – | – | – | -2.2% | -0.7% | -8.3% | |
| – | – | – | – | – | – | – | – | -19.4% | +0.0% | +0.0% | |
| – | – | – | – | – | – | – | – | +21.4% | -2.6% | -2.7% | |
| – | -55.6% | -4.0% | +28.0% | +14.5% | +25.1% | +43.3% | +831.8% | +34.2% | +20.5% | +25.9% | |
| – | -55.6% | -4.0% | +28.0% | +14.5% | +25.1% | +43.3% | +238.5% | +4.9% | -3.8% | +27.8% | |
| – | – | – | +44.1% | -4.4% | +14.5% | -7.9% | -72.6% | +0.6% | +0.8% | +0.8% | |
| – | -47.9% | -65.3% | +53.2% | +48.3% | +37.2% | +91.6% | +13.6% | -47.3% | +105.9% | -4.8% | |
| – | – | – | – | – | – | – | – | – | -25.9% | +200.3% | |
| – | – | -116.2% | – | – | – | – | – | -33.3% | -9.7% | -104.3% | |
| – | – | – | – | – | – | – | – | – | – | – | |
| – | -20.2% | +23.1% | +0.3% | +2.9% | +2.8% | +4.5% | +0.0% | +392.5% | +5.0% | +6.9% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.